ORASURE TECHNOLOGIES, INC Research and Development Expense
ORASURE TECHNOLOGIES, INC (OSUR) reported Research and Development Expense of $9.44 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-07
- ORASURE TECHNOLOGIES, INC research and development expense for the quarter ending 2026-06-30 was $9.44M, a 17.23% decline year-over-year.
- ORASURE TECHNOLOGIES, INC research and development expense for the quarter ending 2026-03-31 was $13.65M, a 42.18% increase year-over-year.
- ORASURE TECHNOLOGIES, INC research and development expense for the quarter ending 2025-12-31 was $11.42M, a 87.58% increase year-over-year.
- ORASURE TECHNOLOGIES, INC research and development expense for the quarter ending 2025-09-30 was $10.11M, a 79.73% increase year-over-year.
- ORASURE TECHNOLOGIES, INC research and development expense for fiscal 2025 was $42.53M, a 63.27% increase from fiscal 2024.
- ORASURE TECHNOLOGIES, INC research and development expense for fiscal 2024 was $26.05M, a 22.77% decline from fiscal 2023.
- ORASURE TECHNOLOGIES, INC research and development expense for fiscal 2023 was $33.73M, a 6.92% decline from fiscal 2022.
- ORASURE TECHNOLOGIES, INC research and development expense for fiscal 2022 was $36.24M, a 6.05% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $9.44M 10-Q · filed 2026-08-07 | $23.09M 10-Q · filed 2026-08-07 | $34.51M derived: sum of 3 quarters · filed 2026-08-07 | $44.62M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | $13.65M 10-Q · filed 2026-05-08 | $25.07M derived: sum of 2 quarters · filed 2026-05-08 | $35.18M derived: sum of 3 quarters · filed 2026-05-08 | $46.58M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | $11.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $21.52M derived: sum of 2 quarters · filed 2026-03-09 | $32.92M derived: sum of 3 quarters · filed 2026-08-07 | $42.53M 10-K · filed 2026-03-09 | ||||
| 2025-09-30 | $10.11M 10-Q · filed 2025-11-05 | $21.51M derived: sum of 2 quarters · filed 2026-08-07 | $31.11M 10-Q · filed 2025-11-05 | $37.20M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | $11.40M 10-Q · filed 2026-08-07 | $21.00M 10-Q · filed 2026-08-07 | $27.09M derived: sum of 3 quarters · filed 2026-08-07 | $32.71M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | $9.60M 10-Q · filed 2026-05-08 | $15.69M derived: sum of 2 quarters · filed 2026-05-08 | $21.31M derived: sum of 3 quarters · filed 2026-05-08 | $27.91M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | $6.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $11.71M derived: sum of 2 quarters · filed 2026-03-09 | $18.31M derived: sum of 3 quarters · filed 2026-03-09 | $26.05M 10-K · filed 2026-03-09 | ||||
| 2024-09-30 | $5.62M 10-Q · filed 2025-11-05 | $12.22M derived: sum of 2 quarters · filed 2025-11-05 | $19.96M 10-Q · filed 2025-11-05 | $26.95M derived: sum of 4 quarters · filed 2026-03-09 | ||||
| 2024-06-30 | $6.60M 10-Q · filed 2025-08-06 | $14.34M 10-Q · filed 2025-08-06 | $21.33M derived: sum of 3 quarters · filed 2026-03-09 | $29.84M derived: sum of 4 quarters · filed 2026-03-09 | ||||
| 2024-03-31 | $7.74M 10-Q · filed 2025-05-07 | $14.73M derived: sum of 2 quarters · filed 2026-03-09 | $23.25M derived: sum of 3 quarters · filed 2026-03-09 | $30.91M derived: sum of 4 quarters · filed 2026-03-09 | ||||
| 2023-12-31 | $6.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $15.51M derived: sum of 2 quarters · filed 2026-03-09 | $23.17M derived: sum of 3 quarters · filed 2026-03-09 | $33.73M 10-K · filed 2026-03-09 | ||||
| 2023-09-30 | $8.52M 10-Q · filed 2024-11-06 | $16.18M derived: sum of 2 quarters · filed 2024-11-06 | $26.74M 10-Q · filed 2024-11-06 | $34.79M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2023-06-30 | $7.66M 10-Q · filed 2024-08-06 | $18.22M 10-Q · filed 2024-08-06 | $26.27M derived: sum of 3 quarters · filed 2025-03-07 | $36.36M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2023-03-31 | $10.56M 10-Q · filed 2024-05-09 | $18.61M derived: sum of 2 quarters · filed 2025-03-07 | $28.70M derived: sum of 3 quarters · filed 2025-03-07 | $38.16M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2022-12-31 | $8.05M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $18.14M derived: sum of 2 quarters · filed 2025-03-07 | $27.60M derived: sum of 3 quarters · filed 2025-03-07 | $36.24M 10-K · filed 2025-03-07 | ||||
| 2022-09-30 | $10.09M 10-Q · filed 2023-11-08 | $9.76M 10-Q · filed 2022-11-08 | $19.55M derived: sum of 2 quarters · filed 2023-11-08 | $28.18M 10-Q · filed 2023-11-08 | $27.24M 10-Q · filed 2022-11-08 | $37.09M derived: sum of 4 quarters · filed 2024-03-11 | ||
| 2022-06-30 | $9.46M 10-Q · filed 2023-08-04 | $9.07M 10-Q · filed 2022-08-09 | $18.10M 10-Q · filed 2023-08-04 | $17.48M 10-Q · filed 2022-08-09 | $27.00M derived: sum of 3 quarters · filed 2024-03-11 | $35.59M derived: sum of 4 quarters · filed 2024-03-11 | ||
| 2022-03-31 | $8.63M 10-Q · filed 2023-05-10 | $8.41M 10-Q · filed 2022-05-10 | $17.53M derived: sum of 2 quarters · filed 2024-03-11 | $26.13M derived: sum of 3 quarters · filed 2024-03-11 | $33.81M derived: sum of 4 quarters · filed 2024-03-11 | |||
| 2021-12-31 | $8.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $17.50M derived: sum of 2 quarters · filed 2024-03-11 | $25.18M derived: sum of 3 quarters · filed 2024-03-11 | $34.17M 10-K · filed 2024-03-11 | ||||
| 2021-09-30 | $8.60M 10-Q · filed 2022-11-08 | $16.28M derived: sum of 2 quarters · filed 2022-11-08 | $25.27M 10-Q · filed 2022-11-08 | $35.73M derived: sum of 4 quarters · filed 2023-03-03 | ||||
| 2021-06-30 | $7.68M 10-Q · filed 2022-08-09 | $16.67M 10-Q · filed 2022-08-09 | $27.13M derived: sum of 3 quarters · filed 2023-03-03 | $35.14M derived: sum of 4 quarters · filed 2023-03-03 | ||||
| 2021-03-31 | $8.99M 10-Q · filed 2022-05-10 | $19.45M derived: sum of 2 quarters · filed 2023-03-03 | $27.46M derived: sum of 3 quarters · filed 2023-03-03 | $34.38M derived: sum of 4 quarters · filed 2023-03-03 | ||||
| 2020-12-31 | $10.46M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $18.46M derived: sum of 2 quarters · filed 2023-03-03 | $25.39M derived: sum of 3 quarters · filed 2023-03-03 | $31.03M 10-K · filed 2023-03-03 | ||||
| 2020-09-30 | $8.01M 10-Q · filed 2021-11-04 | $14.93M derived: sum of 2 quarters · filed 2021-11-04 | $20.57M 10-Q · filed 2021-11-04 | $26.68M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | $6.92M 10-Q · filed 2021-08-05 | $12.57M 10-Q · filed 2021-08-05 | $18.67M derived: sum of 3 quarters · filed 2022-03-01 | $23.29M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-31 | $5.64M 10-Q · filed 2021-05-06 | $11.75M derived: sum of 2 quarters · filed 2022-03-01 | $16.37M derived: sum of 3 quarters · filed 2022-03-01 | $20.90M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | $6.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $10.72M derived: sum of 2 quarters · filed 2022-03-01 | $15.26M derived: sum of 3 quarters · filed 2022-03-01 | $19.63M 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | $4.62M 10-Q · filed 2020-11-05 | $9.15M derived: sum of 2 quarters · filed 2020-11-05 | $13.53M 10-Q · filed 2020-11-05 | $17.58M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-06-30 | $4.54M 10-Q · filed 2020-08-06 | $8.91M 10-Q · filed 2020-08-06 | $12.96M derived: sum of 3 quarters · filed 2021-03-01 | $16.82M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-03-31 | $4.37M 10-Q · filed 2020-05-11 | $8.43M derived: sum of 2 quarters · filed 2021-03-01 | $12.29M derived: sum of 3 quarters · filed 2021-03-01 | $16.55M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2018-12-31 | $4.06M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $7.91M derived: sum of 2 quarters · filed 2021-03-01 | $12.18M derived: sum of 3 quarters · filed 2021-03-01 | $16.25M 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | $3.85M 10-Q · filed 2019-11-08 | $8.12M derived: sum of 2 quarters · filed 2019-11-08 | $12.19M 10-Q · filed 2019-11-08 | $16.02M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-06-30 | $4.26M 10-Q · filed 2019-08-07 | $8.34M 10-Q · filed 2019-08-07 | $12.16M derived: sum of 3 quarters · filed 2020-03-02 | $15.39M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-03-31 | $4.08M 10-Q · filed 2019-05-09 | $7.90M derived: sum of 2 quarters · filed 2020-03-02 | $11.13M derived: sum of 3 quarters · filed 2020-03-02 | $14.47M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2017-12-31 | $3.83M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $7.06M derived: sum of 2 quarters · filed 2020-03-02 | $10.39M derived: sum of 3 quarters · filed 2020-03-02 | $13.37M 10-K · filed 2020-03-02 | ||||
| 2017-09-30 | $3.23M 10-Q · filed 2018-11-08 | $6.57M derived: sum of 2 quarters · filed 2018-11-08 | $9.54M 10-Q · filed 2018-11-08 | $10.74M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-06-30 | $3.34M 10-Q · filed 2018-08-09 | $6.31M 10-Q · filed 2018-08-09 | $7.51M derived: sum of 3 quarters · filed 2019-02-28 | $10.71M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-03-31 | $2.97M 10-Q · filed 2018-05-09 | $4.18M derived: sum of 2 quarters · filed 2019-02-28 | $7.37M derived: sum of 3 quarters · filed 2019-02-28 | $10.36M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2016-12-31 | $1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $4.40M derived: sum of 2 quarters · filed 2019-02-28 | $7.39M derived: sum of 3 quarters · filed 2019-02-28 | $9.75M 10-K · filed 2019-02-28 | ||||
| 2016-09-30 | $3.20M 10-Q · filed 2017-11-09 | $6.18M derived: sum of 2 quarters · filed 2017-11-09 | $8.55M 10-Q · filed 2017-11-09 | $11.24M derived: sum of 4 quarters · filed 2018-02-28 | ||||
| 2016-06-30 | $2.98M 10-Q · filed 2017-08-09 | $5.35M 10-Q · filed 2017-08-09 | $8.04M derived: sum of 3 quarters · filed 2018-02-28 | $10.57M derived: sum of 4 quarters · filed 2018-02-28 | ||||
| 2016-03-31 | $2.37M 10-Q · filed 2017-05-09 | $5.06M derived: sum of 2 quarters · filed 2018-02-28 | $7.58M derived: sum of 3 quarters · filed 2018-02-28 | $10.58M derived: sum of 4 quarters · filed 2018-02-28 | ||||
| 2015-12-31 | $2.69M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $5.22M derived: sum of 2 quarters · filed 2018-02-28 | $8.21M derived: sum of 3 quarters · filed 2018-02-28 | $11.65M 10-K · filed 2018-02-28 | ||||
| 2015-09-30 | $2.52M 10-Q · filed 2016-11-08 | $5.52M derived: sum of 2 quarters · filed 2016-11-08 | $8.96M 10-Q · filed 2016-11-08 | $12.78M derived: sum of 4 quarters · filed 2017-03-14 | ||||
| 2015-06-30 | $3.00M 10-Q · filed 2016-08-08 | $6.44M 10-Q · filed 2016-08-08 | $10.25M derived: sum of 3 quarters · filed 2017-03-14 | $13.24M derived: sum of 4 quarters · filed 2017-03-14 | ||||
| 2015-03-31 | $3.44M 10-Q · filed 2016-05-10 | $7.26M derived: sum of 2 quarters · filed 2017-03-14 | $10.25M derived: sum of 3 quarters · filed 2017-03-14 | $13.02M derived: sum of 4 quarters · filed 2017-03-14 | ||||
| 2014-12-31 | $3.82M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $6.81M derived: sum of 2 quarters · filed 2017-03-14 | $9.58M derived: sum of 3 quarters · filed 2017-03-14 | $12.06M 10-K · filed 2017-03-14 | ||||
| 2014-09-30 | $2.99M 10-Q · filed 2015-11-06 | $5.76M derived: sum of 2 quarters · filed 2015-11-06 | $8.24M 10-Q · filed 2015-11-06 | $10.45M derived: sum of 4 quarters · filed 2015-11-06 | ||||
| 2014-06-30 | $2.77M 10-Q · filed 2015-08-07 | $5.25M 10-Q · filed 2015-08-07 | $7.46M derived: sum of 3 quarters · filed 2015-08-07 | $10.13M derived: sum of 4 quarters · filed 2015-08-07 | ||||
| 2014-03-31 | $2.48M 10-Q · filed 2015-05-08 | $4.69M derived: sum of 2 quarters · filed 2015-05-08 | $7.36M derived: sum of 3 quarters · filed 2015-05-08 | $10.06M derived: sum of 4 quarters · filed 2015-05-08 | ||||
| 2013-12-31 | $2.21M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $4.88M derived: sum of 2 quarters · filed 2015-03-12 | $7.58M derived: sum of 3 quarters · filed 2015-03-12 | $10.93M 10-K · filed 2016-03-14 | ||||
| 2013-09-30 | $2.67M 10-Q · filed 2014-11-07 | $5.36M derived: sum of 2 quarters · filed 2014-11-07 | $8.72M 10-Q · filed 2014-11-07 | $11.61M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-06-30 | $2.69M 10-Q · filed 2014-08-06 | $6.05M 10-Q · filed 2014-08-06 | $8.94M derived: sum of 3 quarters · filed 2015-03-12 | $11.94M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-03-31 | $3.36M 10-Q · filed 2014-05-08 | $6.25M derived: sum of 2 quarters · filed 2015-03-12 | $9.24M derived: sum of 3 quarters · filed 2015-03-12 | $12.36M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2012-12-31 | $2.89M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $5.89M derived: sum of 2 quarters · filed 2015-03-12 | $9.00M derived: sum of 3 quarters · filed 2015-03-12 | $12.45M 10-K · filed 2015-03-12 | ||||
| 2012-09-30 | $2.99M 10-Q · filed 2013-11-07 | $2.99M 10-Q · filed 2012-11-09 | $6.11M derived: sum of 2 quarters · filed 2013-11-07 | $9.55M 10-Q · filed 2013-11-07 | $9.55M 10-Q · filed 2012-11-09 | $12.85M derived: sum of 4 quarters · filed 2014-03-14 | ||
| 2012-06-30 | $3.11M 10-Q · filed 2013-08-08 | $3.11M 10-Q · filed 2012-08-08 | $6.56M 10-Q · filed 2013-08-08 | $6.56M 10-Q · filed 2012-08-08 | $9.85M derived: sum of 3 quarters · filed 2014-03-14 | $15.40M derived: sum of 4 quarters · filed 2014-03-14 | ||
| 2012-03-31 | $3.44M 10-Q · filed 2013-05-09 | $3.44M 10-Q · filed 2012-05-09 | $6.74M derived: sum of 2 quarters · filed 2014-03-14 | $12.29M derived: sum of 3 quarters · filed 2014-03-14 | $17.43M derived: sum of 4 quarters · filed 2014-03-14 | |||
| 2011-12-31 | $3.30M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $8.84M derived: sum of 2 quarters · filed 2014-03-14 | $13.99M derived: sum of 3 quarters · filed 2014-03-14 | $18.41M 10-K · filed 2014-03-14 | $18.41M 10-K · filed 2012-03-14 | |||
| 2011-09-30 | $5.55M 10-Q · filed 2012-11-09 | $10.69M derived: sum of 2 quarters · filed 2012-11-09 | $15.11M 10-Q · filed 2012-11-09 | $19.16M derived: sum of 4 quarters · filed 2013-03-13 | ||||
| 2011-06-30 | $5.14M 10-Q · filed 2012-08-08 | $9.56M 10-Q · filed 2012-08-08 | $13.61M derived: sum of 3 quarters · filed 2013-03-13 | $16.62M derived: sum of 4 quarters · filed 2013-03-13 | ||||
| 2011-03-31 | $4.42M 10-Q · filed 2012-05-09 | $8.47M derived: sum of 2 quarters · filed 2013-03-13 | $11.48M derived: sum of 3 quarters · filed 2013-03-13 | $14.51M derived: sum of 4 quarters · filed 2013-03-13 | ||||
| 2010-12-31 | $4.05M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-13 | $7.06M derived: sum of 2 quarters · filed 2013-03-13 | $10.09M derived: sum of 3 quarters · filed 2013-03-13 | $13.19M 10-K · filed 2013-03-13 | $13.19M 10-K · filed 2012-03-14 | |||
| 2010-09-30 | $3.01M 10-Q · filed 2011-11-09 | $6.04M derived: sum of 2 quarters · filed 2011-11-09 | $9.14M 10-Q · filed 2011-11-09 | |||||
| 2010-06-30 | $3.03M 10-Q · filed 2011-08-05 | $6.14M 10-Q · filed 2011-08-05 | ||||||
| 2009-12-31 | $13.37M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |